81 related articles for article (PubMed ID: 20049849)
1. Potential bias caused by control selection in secondary data analysis: nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke.
Choi NK; Hahn S; Yoon BW; Park BJ
Pharmacoepidemiol Drug Saf; 2010 Jun; 19(6):604-9. PubMed ID: 20049849
[TBL] [Abstract][Full Text] [Related]
2. Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study.
Bak S; Andersen M; Tsiropoulos I; García Rodríguez LA; Hallas J; Christensen K; Gaist D
Stroke; 2003 Feb; 34(2):379-86. PubMed ID: 12574546
[TBL] [Abstract][Full Text] [Related]
3. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
Ilkhanoff L; Lewis JD; Hennessy S; Berlin JA; Kimmel SE
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):513-22. PubMed ID: 15959879
[TBL] [Abstract][Full Text] [Related]
4. Nonaspirin nonsteroidal anti-inflammatory drugs and hemorrhagic stroke risk: the Acute Brain Bleeding Analysis study.
Choi NK; Park BJ; Jeong SW; Yu KH; Yoon BW
Stroke; 2008 Mar; 39(3):845-9. PubMed ID: 18258834
[TBL] [Abstract][Full Text] [Related]
5. Which patients taking non-aspirin non-steroidal anti-inflammatory drugs bleed? A case-control study.
Hochain P; Berkelmans I; Czernichow P; Duhamel C; Tranvouez JL; Lerebours E; Colin R
Eur J Gastroenterol Hepatol; 1995 May; 7(5):419-26. PubMed ID: 7614104
[TBL] [Abstract][Full Text] [Related]
6. Use of non-steroidal anti-inflammatory drugs and risk of ischemic and hemorrhagic stroke in the Australian veteran community.
Mangoni AA; Woodman RJ; Gilbert AL; Knights KM
Pharmacoepidemiol Drug Saf; 2010 May; 19(5):490-8. PubMed ID: 20437458
[TBL] [Abstract][Full Text] [Related]
7. Parity and risk of hemorrhagic strokes.
Jung SY; Bae HJ; Park BJ; Yoon BW;
Neurology; 2010 May; 74(18):1424-9. PubMed ID: 20335561
[TBL] [Abstract][Full Text] [Related]
8. Caffeine-containing medicines increase the risk of hemorrhagic stroke.
Lee SM; Choi NK; Lee BC; Cho KH; Yoon BW; Park BJ
Stroke; 2013 Aug; 44(8):2139-43. PubMed ID: 23743970
[TBL] [Abstract][Full Text] [Related]
9. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT
Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer and regular use of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs.
Kelly JP; Coogan P; Strom BL; Rosenberg L
Pharmacoepidemiol Drug Saf; 2008 Apr; 17(4):322-7. PubMed ID: 18041807
[TBL] [Abstract][Full Text] [Related]
11. Phenylpropanolamine and the risk of hemorrhagic stroke.
Kernan WN; Viscoli CM; Brass LM; Broderick JP; Brott T; Feldmann E; Morgenstern LB; Wilterdink JL; Horwitz RI
N Engl J Med; 2000 Dec; 343(25):1826-32. PubMed ID: 11117973
[TBL] [Abstract][Full Text] [Related]
12. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL
J Am Coll Cardiol; 2004 Mar; 43(6):985-90. PubMed ID: 15028354
[TBL] [Abstract][Full Text] [Related]
13. Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study.
Etminan M; Lévesque L; Fitzgerald JM; Brophy JM
Aliment Pharmacol Ther; 2009 Jun; 29(11):1188-92. PubMed ID: 19298582
[TBL] [Abstract][Full Text] [Related]
14. Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Moride Y; Ducruet T; Boivin JF; Moore N; Perreault S; Zhao S
Arthritis Res Ther; 2005; 7(2):R333-42. PubMed ID: 15743481
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal antiinflammatory drugs and risk of gastrointestinal bleeding among patients on hemodialysis.
Jankovic SM; Aleksic J; Rakovic S; Aleksic A; Stevanovic I; Stefanovic-Stoimenov N; Radosavljevic M; Kostic M; Tesic D; Petrovic B
J Nephrol; 2009; 22(4):502-7. PubMed ID: 19662606
[TBL] [Abstract][Full Text] [Related]
16. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Lewis JD; Kimmel SE; Localio AR; Metz DC; Farrar JT; Nessel L; Brensinger C; McGibney K; Strom BL
Gastroenterology; 2005 Dec; 129(6):1865-74. PubMed ID: 16344055
[TBL] [Abstract][Full Text] [Related]
17. Over the counter non-steroidal anti-inflammatory drugs and risk of gastrointestinal bleeding.
Blot WJ; McLaughlin JK
J Epidemiol Biostat; 2000; 5(2):137-42. PubMed ID: 10890286
[TBL] [Abstract][Full Text] [Related]
18. The relationship of nonsteroidal anti-inflammatory drug use to the risk of breast cancer.
Coogan PF; Rao SR; Rosenberg L; Palmer JR; Strom BL; Zauber AG; Stolley PD; Shapiro S
Prev Med; 1999 Aug; 29(2):72-6. PubMed ID: 10446030
[TBL] [Abstract][Full Text] [Related]
19. Safety of nonsteroidal anti-inflammatory drugs with respect to acute liver disease.
Carson JL; Strom BL; Duff A; Gupta A; Das K
Arch Intern Med; 1993 Jun; 153(11):1331-6. PubMed ID: 8507123
[TBL] [Abstract][Full Text] [Related]
20. COX-2-selective inhibitors and the risk of upper gastrointestinal bleeding in high-risk patients with previous gastrointestinal diseases: a population-based case-control study.
Nørgård B; Pedersen L; Johnsen SP; Tarone RE; McLaughlin JK; Friis S; Sørensen HT
Aliment Pharmacol Ther; 2004 Apr; 19(7):817-25. PubMed ID: 15043523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
